Document is current
Any future updates will be listed below
-
Authors
Vidal-Oliver, Lourdes
Fernández-Avellaneda, Pedro
Fragiotta, Serena https://orcid.org/0000-0002-6214-6270
Corradetti, Giulia https://orcid.org/0000-0001-9213-5575
Borrelli, Enrico https://orcid.org/0000-0003-2815-5031
Dolz-Marco, Rosa https://orcid.org/0000-0002-2963-2541
- License Information
-
More Information
Article History
Received: 22 April 2024
Revised: 13 September 2024
Accepted: 4 November 2024
First Online: 25 November 2024
Competing interests
: LVO reports travel expenses from Bayer; PFA is a consultant for Bayer and Roche; SF reports personal fees from Bayer (Advisor) outside the submitted work; GC none; EB is consultant to Abbvie, Bayer, Hofmann La Roche, Zeiss; RDM is consultant to Heidelberg Engineering and receives research funding from Roche, and Abbvie. The current manuscript received no funding.
